Stay updated with breaking news from Frazier Management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Sierra Oncology (NASDAQ:SRRA – Get Rating) was downgraded by investment analysts at HC Wainwright from a “buy” rating to a “neutral” rating in a research report issued on Wednesday, The Fly reports. They currently have a $55.00 price target on the biotechnology company’s stock. HC Wainwright’s price objective would suggest a potential upside of 0.60% […]
Replimune Group (NASDAQ:REPL – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued on Wednesday, Zacks.com reports. According to Zacks, “Replimune Group, Inc. is a clinical-stage biotechnology company. It discovers, develops and commercializes oncolytic immunotherapy for the treatment of cancer diseases. The company’s […]
Sierra Oncology, Inc. (NASDAQ:SRRA – Get Rating)’s stock price reached a new 52-week high on Wednesday . The stock traded as high as $37.83 and last traded at $37.83, with a volume of 9214 shares trading hands. The stock had previously closed at $36.40. A number of brokerages have commented on SRRA. Oppenheimer boosted their […]
Cogent Biosciences, Inc. (NASDAQ:COGT – Get Rating) shares passed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $6.72 and traded as high as $8.88. Cogent Biosciences shares last traded at $8.81, with a volume of 621,366 shares. Separately, Zacks Investment Research cut Cogent […]